Skip to main content

IL-11 is a potent anti-melanoma factor

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 495))

Abstract

Interleukin 11 (IL-11) is a pleiotropic cytokine initially identified as a factor stimulating proliferation of IL-6-dependet murine plasmacytoma cell line T11651. Today IL-11 is known to interact with variety of haematopoietic and nonhematopoietic cell types (for review see ref. 2). Many of the biological effects of IL-11 are shared with IL-6 since both cytokines share a common receptor subunit ß (gp 130).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O’Hara RM Jr, Leary AC, Sibley B, Clark SC, Williams DA, YangYC, 1990, Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine.Proc Natl Acad Sci USA.87:7512–6.

    Article  PubMed  CAS  Google Scholar 

  2. Du X, Williams DA, 1997, Interleukin-11: review of molecular, cell biology, and clinical use.Blood.89:3897–908.

    PubMed  CAS  Google Scholar 

  3. Mackiewicz A, Koj A, Sehgal PB, 1995, Interleukin-6-type cytokines.Ann NY Acad Sci.762.

    Google Scholar 

  4. Katz A, Shulman LM, Porgador A, Revel M, Feldman M, Eisenbach L, 1993, Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy.J Immunother.13:98–109.

    Article  CAS  Google Scholar 

  5. Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L, 1992, Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.Cancer Res.52:3679–86.

    PubMed  CAS  Google Scholar 

  6. Mackiewicz A, Wiznerowicz M, Roeb E, Karczewska A, Nowak J, Heinrich PC, Rose-John S, 1995, Soluble interleukin 6 receptor is biologically active in vivo.Cytokine.7:142–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dams-Kozlowska, H., Izycki, D., Mackiewicz, a. (2001). IL-11 is a potent anti-melanoma factor. In: Mackiewicz, A., Kurpisz, M., Żeromski, J. (eds) Progress in Basic and Clinical Immunology. Advances in Experimental Medicine and Biology, vol 495. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0685-0_54

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0685-0_54

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5194-8

  • Online ISBN: 978-1-4615-0685-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics